Ruff Shamim

CIK 00016859862 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001685986

Recent Transactions

50 trades

Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−780→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−443→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−2,137→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−7,359→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−3,334→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−576→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−1,405→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,000→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$164.53/sh−8,235→ 7,359 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$92.20/sh+319→ 15,594 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-07-28−319→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$92.20/sh+6,666→ 15,275 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-07-28−1,250→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$92.20/sh+1,250→ 8,609 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-07-28−6,666→ 3,334 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-07$93.61/sh+454→ 5,677 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-06-07$73.68/sh+576→ 576 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-07$93.61/sh+1,682→ 7,359 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-06-07+2,137→ 2,137 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-10$34.76/sh+4,215→ 10,963 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-03-10−199→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-03-10−1,326→ 443 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-03-10−4,215→ 1,405 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-10$34.76/sh+1,326→ 6,748 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-10$27.32/sh+199→ 5,422 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-10$83.73/sh−5,740→ 5,223 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-06-08$34.76/sh+1,222→ 1,340 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2022-06-08+5,620→ 5,620 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-06-08$34.76/sh+3,883→ 5,223 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2022-06-08$24.02/sh+1,769→ 1,769 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-01-03$27.32/sh+118→ 118 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2022-01-03$16.14/sh+199→ 199 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-06-10+5,000→ 5,000 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-06-10$83.24/sh+780→ 780 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15$52.85/sh+319→ 319 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15+1,250→ 1,250 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15+10,000→ 10,000 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Restricted Stock Units
2018-05-22−4,432→ 0 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-05-22$89.22/sh−1,305→ 31,936 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-05-22+4,432→ 33,241 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2018-03-15−2,031→ 10,066 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-03-15$13.90/sh+469→ 27,514 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-03-15$81.22/sh−80→ 27,434 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-03-15$26.24/sh+2,031→ 29,465 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2018-03-15−469→ 6,134 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2018-03-15$81.22/sh−656→ 28,809 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2018-03-05+70,000→ 70,000 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2017-11-06$55.00/sh−10,000→ 27,045 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Non-Qualified Stock Options (right to buy)
2017-11-06$14.76/sh−10,000→ 31,144 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2017-11-06$14.76/sh+10,000→ 37,045 total

Companies

Recent Filings

Address

215 FIRST STREET SUITE 415

CAMBRIDGE, MA, 02142

View on SEC.gov